# Highlight Capital: portfolio, investments and team

> Highlight Capital is a vc firm based in China. 78 investments on record, 11 in the last 12 months, latest May 2026. Portfolio, stages, co-investors and team.

Source: https://millionrounds.com/fund/highlight-capital (Millionrounds; every figure on the page links to its filing or article)

China · [Investor](https://millionrounds.com/investors)

# Highlight Capital

Last cheque observed May 2026; 78 cheques on record.

Email

Deploying now New fund $904K, Nov 2022 VC firm Website unconfirmed

Series B Venture Series A Healthcare Technology

Follow Highlight Capital and see its new cheques in your feed. [Start following](https://millionrounds.com/login?join=1&why=follow&next=%2Ffund%2Fhighlight-capital)

Deploying now

**38%** of best year **11** **cheques in 12 months**, 78 on record

Since the last cheque **176** days **00** hrs **00** min **00** sec

Median round **$25M** Rounds led **0 of 78** Sole investor **23 rounds** Mostly in **United States, 36%**

Pitch Highlight Capital

Another investor of this name exists, and we could not establish from the rounds which of them the press meant. Treat the record below as possibly belonging to either. [Tell us which](https://millionrounds.com/corrections?slug=highlight-capital) if you know.

## Highlight Capital highlights

- 01 11 cheques in the last 12 months
- 02 Mostly Series B and Venture: 54% of its rounds
- 03 Sole investor in 23 rounds, median $14M

## What they do

- **Type:** VC firm
- **Cheque size:** Not stated
- **Sectors:** Healthcare Technology
- **Based in:** China
- **Cold pitches:** Accepted

A website was listed for this organisation, but we could not confirm it belongs to the firm that wrote these cheques. Either the site never mentions them, or it turned out to be a different company sharing the name. We show neither it nor anything read from it. [Tell us the right one](https://millionrounds.com/corrections?slug=highlight-capital).

## The record

Every round we can evidence, newest first **78 appearances**

- **2026** 8 rounds
- **May** **[Vivatides Therapeutics](https://millionrounds.com/company/vivatides-therapeutics)** Series A · Ventureburn **$54M** With 3 others
- **May** **[Nuclidium](https://millionrounds.com/company/nuclidium)** Series B · CH **$34M** With 3 others
- **Apr** **[ImageneBio](https://millionrounds.com/company/imagenebio)** US **$30M** With 4 others
- **Apr** **[Allegria Therapeutics](https://millionrounds.com/company/allegria-therapeutics)** Grant · CH **$1.5M** Sole investor
- **Feb** **[Spirit AI](https://millionrounds.com/company/spirit-ai)** Series A · CN · Ventureburn **$250M** With 7 others
- **Jan** **[Spurious](https://millionrounds.com/company/spurious)** Seed **$35M** Sole investor
- **Jan** **[Yiteng Medical](https://millionrounds.com/company/yiteng-medical)** Series A **$14M** Sole investor
- **Jan** **[Realm of Illumination](https://millionrounds.com/company/realm-of-illumination)** Venture **Undisclosed** With 4 others
- **2025** 25 rounds
- **Dec** **[Shouxing Technology](https://millionrounds.com/company/shouxing-technology)** Venture · US **Undisclosed** With 3 others
- **Dec** **[T-CURX](https://millionrounds.com/company/t-curx)** Series A · DE **$20M** With 1 other
- **Nov** **[Novachip Microelectronics](https://millionrounds.com/company/novachip-microelectronics)** Pre-seed **$14M** Sole investor
- **Oct** **[AsiaSonic Semiconductor](https://millionrounds.com/company/asiasonic-semiconductor)** Series B **$14M** Sole investor
- **Oct** **[USUN BIO](https://millionrounds.com/company/usun-bio)** Venture **Undisclosed** Sole investor
- **Oct** **[Ultra Social](https://millionrounds.com/company/ultra-social)** Series B · JP **$7.6M** With 2 others
- **Sept** **[Yuansheng Intelligence](https://millionrounds.com/company/yuansheng-intelligence)** Venture **Undisclosed** Sole investor
- **Sept** **[Sieran Medical](https://millionrounds.com/company/sieran-medical)** Venture **$14M** With 1 other
- **Sept** **[E-nitiate Biopharmaceuticals](https://millionrounds.com/company/e-nitiate-biopharmaceuticals)** Series B **$28M** Sole investor
- **Sept** **[Ennovabio](https://millionrounds.com/company/ennovabio)** Venture **Undisclosed** With 1 other
- **Aug** **[Base Therapeutics](https://millionrounds.com/company/base-therapeutics)** Venture **Undisclosed** With 2 others
- **Aug** **[XINGYUN GROUP](https://millionrounds.com/company/xingyun-group)** Venture **Undisclosed** With 5 others
- **Aug** **[Methuselah](https://millionrounds.com/company/methuselah)** Series B **$15M** With 2 others
- **Jul** **[Nuclidium](https://millionrounds.com/company/nuclidium)** Series B · CH · DTCF DeepTech & Climate Fonds **$99M** With 11 others
- **Jul** **[Abiochem Biotechnology](https://millionrounds.com/company/abiochem-biotechnology)** Series D **$63M** With 2 others
- **Jul** **[Qinghui Liannuo](https://millionrounds.com/company/qinghui-liannuo)** Venture **Undisclosed** Sole investor
- **Jul** **[VelaVigo](https://millionrounds.com/company/velavigo)** Seed **$60M** With 5 others
- **Jun** **[Tianchen Biotechnology](https://millionrounds.com/company/tianchen-biotechnology)** Series C **$28M** With 1 other
- **Jun** **[Shenandoah Therapeutics](https://millionrounds.com/company/shenandoah-therapeutics)** Seed · US **$20M** With 1 other
- **Jun** **[Arthrosi Therapeutics](https://millionrounds.com/company/arthrosi-therapeutics)** Series E · US **$153M** Sole investor
- **May** **[Nuevocor](https://millionrounds.com/company/nuevocor)** Series B · SG **$45M** With 3 others
- **May** **[LongBio Pharma](https://millionrounds.com/company/longbio-pharma)** Series C **$29M** With 2 others
- **May** **[Acchrom Tech](https://millionrounds.com/company/acchrom-tech)** Series B **$14M** With 1 other
- **Feb** **[Jiamai shares](https://millionrounds.com/company/jiamai-shares)** Venture **$14M** With 1 other
- **Jan** **[Bibost Automotive Electronics](https://millionrounds.com/company/bibost-automotive-electronics)** Series B **$41M** With 3 others
- **2024** 7 rounds
- **Sept** **[Tachem](https://millionrounds.com/company/tachem)** Series B **$9.3M** With 3 others
- **Sept** **[Hope Medicine](https://millionrounds.com/company/hope-medicine)** Series B **$19M** With 2 others
- **Jul** **[MoonBiotech](https://millionrounds.com/company/moonbiotech)** Series C **$41M** With 2 others
- **Apr** **[MCT millimeter intelligence](https://millionrounds.com/company/mct-millimeter-intelligence)** Seed **$14M** Sole investor
- **Mar** **[EdgeRock](https://millionrounds.com/company/edgerock)** Series A **$14M** Sole investor
- **Feb** **[Shifan Microelectronics](https://millionrounds.com/company/shifan-microelectronics)** Seed **$14M** With 1 other
- **Feb** **[Hydropeng Technology](https://millionrounds.com/company/hydropeng-technology)** Seed **$1.4M** Sole investor

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

## The team

Named by the firm itself, on a filing, its Form ADV or its company registration **1 named**

ND **Neelam Desai** Mr. Desai is the Manager of General Partner. i Filing they signed

We also hold **1** person at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

New fund on file

**$904K**

raised in Nov 2022

From its SEC filing, not a journalist: a firm that has just raised has money to deploy.

## The cheque

Series B Venture Series A

Median round joined **$25M** the round, not its cheque Alone, median **$14M**

Led 0 of 78 rounds **0%**

- **Sole investor:** 23 rounds
- **Last cheque:** May 2026

Rounds by stage said on their site

- Series B *20*
- Venture *17*
- Series A *11*
- Series C *8*
- Seed *7*
- Pre-seed *5*

Cheques by month Led Joined

Nov 2023 Oct 2026

Often in the room with

- [Qiming Venture Partners](https://millionrounds.com/fund/qiming-venture-partners) 7
- [CICC](https://millionrounds.com/fund/cicc) 5
- [Shunwei Capital](https://millionrounds.com/fund/shunwei-capital) 5
- [CDH Investments](https://millionrounds.com/fund/cdh-investments) 4
- [HSG](https://millionrounds.com/fund/hsg) 4
- [Addor Capital](https://millionrounds.com/fund/addor-capital) 3

**Pitching Highlight Capital?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque.

Add to your CRM *→*

## Who they invest alongside

The investors most often in the same rounds as Highlight Capital. A count of rooms they were both in, not a relationship either has claimed.

[**Qiming Venture Partners** VC firm **7** rounds together](https://millionrounds.com/fund/qiming-venture-partners)[**CICC** Investment bank **5** rounds together](https://millionrounds.com/fund/cicc)[**Shunwei Capital** VC firm **5** rounds together](https://millionrounds.com/fund/shunwei-capital)[**CDH Investments** Private equity **4** rounds together](https://millionrounds.com/fund/cdh-investments)[**HSG** VC firm **4** rounds together](https://millionrounds.com/fund/hsg)[**Addor Capital** VC firm **3** rounds together](https://millionrounds.com/fund/addor-capital)[**Baidu Ventures** VC firm **3** rounds together](https://millionrounds.com/fund/baidu-ventures)[**Cowin Capital** VC firm **3** rounds together](https://millionrounds.com/fund/cowin-venture-capital)[**Fortune Venture Capital** VC firm **3** rounds together](https://millionrounds.com/fund/fortune-capital)[**KurmaPartners** VC firm **3** rounds together](https://millionrounds.com/fund/kurmapartners)[**Legend Star** VC firm **3** rounds together](https://millionrounds.com/fund/legend-star)[**Matrix Partners China** VC firm **3** rounds together](https://millionrounds.com/fund/matrix-partners-china-2)

## Recently backed

The latest companies Highlight Capital put money into.

[**ImageneBio** $30M · Apr 2026](https://millionrounds.com/company/imagenebio)[**Allegria Therapeutics** $1.5M · Apr 2026](https://millionrounds.com/company/allegria-therapeutics)[**Ultra Social** $7.6M · Oct 2025](https://millionrounds.com/company/ultra-social)[**VelaVigo** $60M · Jul 2025](https://millionrounds.com/company/velavigo)[**Nuevocor** $45M · May 2025](https://millionrounds.com/company/nuevocor)[**Jiamai shares** $14M · Feb 2025](https://millionrounds.com/company/jiamai-shares)

## Quick answers about Highlight Capital

### What does Highlight Capital invest in?

Highlight Capital invests most often at Series B and Venture (54% of the rounds on record), in sectors such as Healthcare and Technology.

### How active is Highlight Capital?

78 investments on record, 11 of them in the last 12 months. The most recent was in May 2026.

### What has Highlight Capital invested in recently?

Its most recent investments on record: Vivatides Therapeutics (Series A, May 2026), Nuclidium (Series B, May 2026) and ImageneBio (Undisclosed round, Apr 2026).

### How big are Highlight Capital's cheques?

The median round it joins is $25M.

### Does Highlight Capital lead rounds?

Rarely, if at all: none of its 78 investments on record names it as the lead.

### Where does Highlight Capital invest?

Most of the companies it backs are in the United States (36%), Switzerland (27%) and China (9%).

### Is Highlight Capital investing now?

Yes: it is actively investing, with 11 investments in the last 12 months.

### Who does Highlight Capital invest alongside?

Most often Qiming Venture Partners (7 rounds together), CICC (5 rounds together) and Shunwei Capital (5 rounds together).

## Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=highlight-capital) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=highlight-capital)